Delta Diagnostics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Delta Diagnostics - overview
Established
2018
Location
Rotterdam, -, Netherlands
Primary Industry
Biotechnology
About
Founded in 2018 by Bart de Boer, and based in the Netherlands, Delta Diagnostics BV, as a spin-off from TNO, operates as a biotechnology research company that commercializes a patented biosensor technology for drug discovery and research. In May 2023, Delta Diagnostics BV raised EUR 5. 25 million in venture funding from investors InnovationQuarter. As of 2023, the company is being led by its CEO, Guy Dewil.
The company’s partners include UNIQ, Rabobank, PhotonDelta, TNO, etc. The firm commercializes and develops patented integrated photonics to create highly sensitive and selective biosensors. The company employs photonic integrated circuits to simplify and reduce the cost of biosensing, enabling the detection of analytes in biological or chemical processes. This technology finds applications in illness monitoring, drug discovery, and identifying pollutants, disease-causing microorganisms, and disease markers in body fluids.
The company intends to use the May 2023 funding to the growth of its business and make its photonic integrated circuit biosensor technology.
Current Investors
InnovationQuarter
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Biotechnology
Website
www.deltadiagnostics.nl/
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Delta Diagnostics - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.